EMA-话题@MedSci

#EMA#

580篇内容 | 2457人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317353, encodeId=23a8131e353f0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤, objectType=article, longId=111593, objectId=0e981115938d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e981115938d, replyNumber=0, likeNumber=59, createdTime=2017-09-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e981115938d, moduleTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e981115938d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317352, encodeId=c12a131e352fb, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Br J Haematol：吸烟和饮酒与骨髓增生异常综合征风险的影响不同（前瞻性研究）, objectType=article, longId=111580, objectId=994911158023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=994911158023, replyNumber=0, likeNumber=54, createdTime=2017-09-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=994911158023, moduleTitle=Br J Haematol：吸烟和饮酒与骨髓增生异常综合征风险的影响不同（前瞻性研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=994911158023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317351, encodeId=3c11131e35157, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：镰状细胞病患者慢性器官损害的前瞻性评估, objectType=article, longId=111211, objectId=cf2711121125, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf2711121125, replyNumber=0, likeNumber=64, createdTime=2017-08-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf2711121125, moduleTitle=Am J Hematol：镰状细胞病患者慢性器官损害的前瞻性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf2711121125)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317350, encodeId=758f131e35080, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=EMA将搬离伦敦，19个欧盟成员国竞逐，全球第2大药监机构花落谁家？, objectType=article, longId=110887, objectId=b04e11088e71, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b04e11088e71, replyNumber=0, likeNumber=62, createdTime=2017-08-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b04e11088e71, moduleTitle=EMA将搬离伦敦，19个欧盟成员国竞逐，全球第2大药监机构花落谁家？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b04e11088e71)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317349, encodeId=842d131e34904, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：抗体水平对血栓相关的原发性抗磷脂综合征患者的免疫系统的影响较大, objectType=article, longId=110478, objectId=65081104e895, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=65081104e895, replyNumber=0, likeNumber=59, createdTime=2017-08-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=65081104e895, moduleTitle=Am J Hematol：抗体水平对血栓相关的原发性抗磷脂综合征患者的免疫系统的影响较大, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=65081104e895)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317348, encodeId=db32131e3480e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：Eliglustat长期治疗成人1型戈谢病的结局如何？, objectType=article, longId=110477, objectId=78991104e7d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78991104e7d6, replyNumber=0, likeNumber=91, createdTime=2017-08-23, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78991104e7d6, moduleTitle=Am J Hematol：Eliglustat长期治疗成人1型戈谢病的结局如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78991104e7d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317347, encodeId=543b131e34730, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：来那度胺对自体干细胞移植后的骨髓瘤患者的治疗效果。, objectType=article, longId=109233, objectId=ffd01092330d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ffd01092330d, replyNumber=0, likeNumber=92, createdTime=2017-08-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ffd01092330d, moduleTitle=Lancet haemat：来那度胺对自体干细胞移植后的骨髓瘤患者的治疗效果。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ffd01092330d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317346, encodeId=a7d0131e346cf, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Brit J Haematol：慢性淋巴细胞白血病患者发生大出血与什么相关？, objectType=article, longId=108882, objectId=37791088826d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37791088826d, replyNumber=0, likeNumber=67, createdTime=2017-08-17, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37791088826d, moduleTitle=Brit J Haematol：慢性淋巴细胞白血病患者发生大出血与什么相关？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37791088826d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317345, encodeId=a1eb131e3459f, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet haemat：检测外周静脉导管性静脉炎所存在的问题。, objectType=article, longId=108620, objectId=c1e4108620dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1e4108620dc, replyNumber=0, likeNumber=70, createdTime=2017-08-14, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1e4108620dc, moduleTitle=Lancet haemat：检测外周静脉导管性静脉炎所存在的问题。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1e4108620dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317344, encodeId=45c3131e34491, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Brit J Haematol:滤泡性淋巴瘤临床试验评效标准是否可取消骨髓活检？, objectType=article, longId=108284, objectId=1f1c10828430, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f1c10828430, replyNumber=0, likeNumber=76, createdTime=2017-08-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f1c10828430, moduleTitle=Brit J Haematol:滤泡性淋巴瘤临床试验评效标准是否可取消骨髓活检？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f1c10828430)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317343, encodeId=0727131e34328, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：Brentuximab vedotin治疗复发/难治性系统性间变性大细胞淋巴瘤的大型观察性研究（意大利真实世界研究）, objectType=article, longId=107875, objectId=aa2c10e8756a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa2c10e8756a, replyNumber=0, likeNumber=61, createdTime=2017-08-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa2c10e8756a, moduleTitle=Haematologica：Brentuximab vedotin治疗复发/难治性系统性间变性大细胞淋巴瘤的大型观察性研究（意大利真实世界研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa2c10e8756a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317342, encodeId=4e96131e34281, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Crit Rev Oncol Hematol：转移性/进展期胃癌患者疾病进展后，是否行三线全身治疗？, objectType=article, longId=107300, objectId=b3d610e300a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3d610e300a0, replyNumber=0, likeNumber=46, createdTime=2017-08-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3d610e300a0, moduleTitle=Crit Rev Oncol Hematol：转移性/进展期胃癌患者疾病进展后，是否行三线全身治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3d610e300a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317341, encodeId=41d6131e341e3, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：成人镰状细胞病患者慢性器官损害的前瞻性评估, objectType=article, longId=107293, objectId=512610e2930e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=512610e2930e, replyNumber=0, likeNumber=88, createdTime=2017-08-02, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=512610e2930e, moduleTitle=Am J Hematol：成人镰状细胞病患者慢性器官损害的前瞻性评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=512610e2930e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317340, encodeId=113b131e34031, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：天门冬酰胺酶治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤，强化用药时间的疗效是否会更佳？, objectType=article, longId=107218, objectId=590b10e21832, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=590b10e21832, replyNumber=0, likeNumber=68, createdTime=2017-08-01, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=590b10e21832, moduleTitle=Haematologica：天门冬酰胺酶治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤，强化用药时间的疗效是否会更佳？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=590b10e21832)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317339, encodeId=cae6131e33922, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤，安全且有效, objectType=article, longId=107096, objectId=7f2310e09663, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f2310e09663, replyNumber=0, likeNumber=100, createdTime=2017-07-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f2310e09663, moduleTitle=Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤，安全且有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f2310e09663)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317338, encodeId=fb1a131e338d6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：神经参与了镰状细胞性贫血患者并发血管阻塞性危象的过程, objectType=article, longId=106985, objectId=9dcb10698532, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dcb10698532, replyNumber=0, likeNumber=75, createdTime=2017-07-29, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dcb10698532, moduleTitle=Am J Hematol：神经参与了镰状细胞性贫血患者并发血管阻塞性危象的过程, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dcb10698532)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317337, encodeId=ca9b131e337ed, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Am J Hematol：利妥昔单抗治疗非霍奇金淋巴瘤对中枢神经系统复发是否有效？, objectType=article, longId=106878, objectId=53341068e82b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53341068e82b, replyNumber=0, likeNumber=50, createdTime=2017-07-28, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53341068e82b, moduleTitle=Am J Hematol：利妥昔单抗治疗非霍奇金淋巴瘤对中枢神经系统复发是否有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53341068e82b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317336, encodeId=5279131e336f0, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：雷帕霉素或能治疗获得性再生障碍性贫血, objectType=article, longId=106729, objectId=7cc2106e29e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cc2106e29e5, replyNumber=0, likeNumber=67, createdTime=2017-07-27, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cc2106e29e5, moduleTitle=Haematologica：雷帕霉素或能治疗获得性再生障碍性贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cc2106e29e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317335, encodeId=380d131e335d5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好, objectType=article, longId=106541, objectId=fee61065410a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fee61065410a, replyNumber=0, likeNumber=62, createdTime=2017-07-26, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fee61065410a, moduleTitle=Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fee61065410a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317334, encodeId=a3d6131e33465, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=JCLA：Mindray CAL 8000（BC-6800和SC-120）血液分析仪和slidemaker/stainer的性能评估, objectType=article, longId=106522, objectId=9b9710652255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b9710652255, replyNumber=0, likeNumber=84, createdTime=2017-07-26, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b9710652255, moduleTitle=JCLA：Mindray CAL 8000（BC-6800和SC-120）血液分析仪和slidemaker/stainer的性能评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b9710652255)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤

2017-09-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Br J Haematol：吸烟和饮酒与骨髓增生异常综合征风险的影响不同（前瞻性研究）

2017-09-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：镰状细胞病患者慢性器官损害的前瞻性评估

2017-08-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

EMA将搬离伦敦，19个欧盟成员国竞逐，全球第2大药监机构花落谁家？

2017-08-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：抗体水平对血栓相关的原发性抗磷脂综合征患者的免疫系统的影响较大

2017-08-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：Eliglustat长期治疗成人1型戈谢病的结局如何？

2017-08-23

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：来那度胺对自体干细胞移植后的骨髓瘤患者的治疗效果。

2017-08-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Brit J Haematol：慢性淋巴细胞白血病患者发生大出血与什么相关？

2017-08-17

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet haemat：检测外周静脉导管性静脉炎所存在的问题。

2017-08-14

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Brit J Haematol:滤泡性淋巴瘤临床试验评效标准是否可取消骨髓活检？

2017-08-11

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：Brentuximab vedotin治疗复发/难治性系统性间变性大细胞淋巴瘤的大型观察性研究（意大利真实世界研究）

2017-08-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Crit Rev Oncol Hematol：转移性/进展期胃癌患者疾病进展后，是否行三线全身治疗？

2017-08-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：成人镰状细胞病患者慢性器官损害的前瞻性评估

2017-08-02

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：天门冬酰胺酶治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤，强化用药时间的疗效是否会更佳？

2017-08-01

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：来那度胺单药治疗复发性/难治性套细胞淋巴瘤，安全且有效

2017-07-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：神经参与了镰状细胞性贫血患者并发血管阻塞性危象的过程

2017-07-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Am J Hematol：利妥昔单抗治疗非霍奇金淋巴瘤对中枢神经系统复发是否有效？

2017-07-28

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：雷帕霉素或能治疗获得性再生障碍性贫血

2017-07-27

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Haematologica：Vosaroxin联合地西他滨治疗老年急性白血病或骨髓增生异常综合征，有效且耐受性良好

2017-07-26

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

JCLA：Mindray CAL 8000（BC-6800和SC-120）血液分析仪和slidemaker/stainer的性能评估

2017-07-26

科室
- - 订阅+
  - 更多科室
工具
服务